Steven E. Selden, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-243-1414 Fax: 860-286-0510 |
Brett L Wasserlauf, MD Orthopaedic Surgery - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr, Bloomfield, CT 06002 Phone: 860-242-3000 Fax: 860-286-9547 |
Scott Allen Bissell, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr, Bloomfield, CT 06002 Phone: 860-242-3000 Fax: 860-286-9547 |
Andrew G Gabow, M.D. Orthopaedic Surgery - Hand Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-243-1414 Fax: 860-286-0510 |
Dr. Michael P Kruger, MD Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 673 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-9910 |
Robert Allen Green, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 421 Cottage Grove Rd, Suite A, Bloomfield, CT 06002 Phone: 860-286-0182 Fax: 860-286-7839 |
Lili Schindelar, MD Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 35 Jolley Dr Ste 301, Bloomfield, CT 06002 Phone: 860-242-3000 |
News Archive
"Tanzania is to become the first country in the world to move exclusively to using syringes that self-destruct after a British entrepreneur played the health minister undercover footage of children being injected with used needles," the Guardian reports.
John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 cancer centers, will bring together leading cancer experts, for presentation and discussion of the latest developments and implications of cell therapy and interventional immunology in oncology, on Friday, June 7 from 7:00am to 1:30pm.
Scientists working out of Trinity College Dublin, Maynooth University, and Queen Mary University of London have unearthed a potential new preventative option to combat Ascaris roundworm infection.
The National Patient Advocate Foundation (NPAF) – a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels – delivered a letter to Dr. William Hazel Jr., M.D., Secretary of Health and Human Resources and Chair of Virginia Governor's Health Information Technology Advisory Commission (HITAC), bringing attention to the need to ensure patients' right to privacy in the state's health information exchange (HIE).
Welichem announced that the Company has begun to enroll patients in a Phase IIa clinical trial with its lead candidate, WBI-1001. The Phase IIa clinical trial is a 12-Week, double-blinded, placebo-controlled study. The objectives of the trial are to evaluate the efficacy of the WBI-1001 cream in comparison to the vehicle and also to evaluate the safety and tolerability of the cream in patients with psoriasis.
› Verified 5 days ago